2:38newsJanuary 25, 2022Pfizer starts trials for omicron-specific boosterThe pharmaceutical company announced the beginning of its trials, with more than 1,400 patients set to receive one or more doses of the variant-based vaccine.Up Next in newsCOVID cases drop in some parts of the country, spike in othersJanuary 24, 2022Sandra Day O'Connor, 1st woman on Supreme Court, dies at 93December 1, 20231 year after Club Q tragedy, loved ones share treasured memories of lives lostNovember 19, 2023